Angiogenesis in symptomatic intracranial atherosclerosis -: Predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence

被引:40
作者
Arenillas, JF
Alvarez-Sabín, J
Montaner, J
Rosell, A
Molina, CA
Rovira, A
Ribó, M
Sánchez, E
Quintana, M
机构
[1] Vall Hebron Univ Hosp, Neurovasc Unit, Barcelona, Spain
[2] Vall Hebron Univ Hosp, Neurovasc Res Lab, Barcelona, Spain
[3] Vall Hebron Univ Hosp, Magnet Resonance Unit, Barcelona, Spain
关键词
angiogenesis; atherosclerosis; intracranial; endostatins; intracranial stenosis; vascular endothelial growth factor;
D O I
10.1161/01.STR.0000149617.65372.5d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Angiogenesis may be beneficial in chronic myocardial and limb ischemia, but its role in intracranial atherosclerosis remains unknown. We aimed to investigate the relationship between the pro-angiogenic vascular endothelial growth factor (VEGF) and the anti-angiogenic endostatin, and the extent and risk of recurrence of symptomatic intracranial atherosclerosis. Methods-Of a total of 94 consecutive patients with symptomatic intracranial stenoses, 40 fulfilled all inclusion criteria. Intracranial stenoses were confirmed by magnetic resonance angiography. Magnetic resonance imaging (MRI) including diffusion-weighted sequences was conducted. Plasmatic VEGF and endostatin were determined from blood samples obtained 3 months after stroke onset, and patients were followed-up thereafter. Results-A total of 144 intracranial stenoses were confirmed (median number per patient=3). Endostatin/VEGF ratio gradually augmented with the increasing number of intracranial stenoses (r=0.35, P=0.02). Diabetes mellitus (OR, 6.04; CI, 1.1 to 32.2; P=0.03) and a higher endostatin/VEGF ratio (OR, 15.7; CI, 2.2 to 112.3; P=0.006) were independently associated with a greater extent of intracranial atherosclerosis. During a median follow-up of 13 months, 8 patients (20%) experienced a new cerebral ischemic event. A higher baseline endostatin concentration was an independent predictor of new events (hazard ratio, 7.24; CI, 1.6 to 33.8; P=0.011) in a Cox regression model after adjustment for age, sex, number of stenotic vessels, and risk factors. Patients with a higher endostatin level had a lower survival free of new events (P=0.01, log-rank test). Conclusions-A predominance of the inhibitor endostatin within the endogenous angiogenic response is associated with a greater extent and risk of recurrence of symptomatic intracranial atherosclerosis, suggesting that angiogenesis may be beneficial in this condition.
引用
收藏
页码:92 / 97
页数:6
相关论文
共 24 条
[1]   High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis [J].
Arenillas, JF ;
Molina, CA ;
Chacón, P ;
Rovira, A ;
Montaner, J ;
Coscojuela, P ;
Sánchez, E ;
Quintana, M ;
Alvarez-Sabín, J .
NEUROLOGY, 2004, 63 (01) :27-32
[2]   Progression and clinical recurrence of symptomatic middle cerebral artery stenosis -: A long-term follow-up transcranial Doppler ultrasound study [J].
Arenillas, JF ;
Molina, CA ;
Montaner, J ;
Abilleira, S ;
González-Sánchez, MA ;
Alvarez-Sabín, J .
STROKE, 2001, 32 (12) :2898-2904
[3]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[4]   Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[5]  
Chimowitz M, 2004, STROKE, V35, P235
[6]   THE WARFARIN-ASPIRIN SYMPTOMATIC INTRACRANIAL DISEASE STUDY [J].
CHIMOWITZ, MI ;
KOKKINOS, J ;
STRONG, J ;
BROWN, MB ;
LEVINE, SR ;
SILLIMAN, S ;
PESSIN, MS ;
WEICHEL, E ;
SILA, CA ;
FURLAN, AJ ;
KARGMAN, DE ;
SACCO, RL ;
WITYK, RJ ;
FORD, G ;
FAYAD, PB .
NEUROLOGY, 1995, 45 (08) :1488-1493
[7]   Endostatin induces endothelial cell apoptosis [J].
Dhanabal, M ;
Ramchandran, R ;
Waterman, MJF ;
Lu, H ;
Knebelmann, B ;
Segal, M ;
Sukhatme, VP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) :11721-11726
[8]   Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury [J].
Hutter, R ;
Sauter, BV ;
Reis, ED ;
Roque, M ;
Vorchheimer, D ;
Carrick, FE ;
Fallon, JT ;
Fuster, V ;
Badimon, JJ .
CIRCULATION, 2003, 107 (12) :1658-1663
[9]  
Issa R, 1999, LAB INVEST, V79, P417
[10]   Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus [J].
Kornowski, R .
CORONARY ARTERY DISEASE, 2003, 14 (01) :61-64